New-onset diabetes after transplantation: risk factors and clinical impact
- PMID: 21295510
- DOI: 10.1016/j.diabet.2010.09.003
New-onset diabetes after transplantation: risk factors and clinical impact
Abstract
With improvements in patient and graft survival, increasing attention has been placed on complications that contribute to long-term patient morbidity and mortality. New-onset diabetes after transplantation (NODAT) is a common complication of solid-organ transplantation, and is a strong predictor of graft failure and cardiovascular mortality in the transplant population. Risk factors for NODAT in transplant recipients are similar to those in non-transplant patients, but transplant-specific risk factors such as hepatitis C (HCV) infection, corticosteroids and calcineurin inhibitors play a dominant role in NODAT pathogenesis. Management of NODAT is similar to type 2 diabetes management in the general population. However, adjusting the immunosuppressant regimen to improve glucose tolerance must be weighed against the risk of allograft rejection. Lifestyle modification is currently the strategy with the least risk and the most benefit.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.
Similar articles
-
New-onset diabetes after transplantation: a review of recent literature.Curr Opin Organ Transplant. 2009 Aug;14(4):375-9. doi: 10.1097/MOT.0b013e32832dbb98. Curr Opin Organ Transplant. 2009. PMID: 19542891 Review.
-
Nutritional and metabolic issues in solid organ transplantation: targets for future research.J Ren Nutr. 2009 Jan;19(1):111-22. doi: 10.1053/j.jrn.2008.10.020. J Ren Nutr. 2009. PMID: 19121784 Review.
-
Predicting, managing and preventing new-onset diabetes after transplantation.Minerva Endocrinol. 2012 Sep;37(3):233-46. Minerva Endocrinol. 2012. PMID: 22766890 Review.
-
New-onset diabetes mellitus after solid organ transplantation.Transpl Int. 2009 May;22(5):519-30. doi: 10.1111/j.1432-2277.2008.00800.x. Epub 2008 Nov 20. Transpl Int. 2009. PMID: 19040489 Review.
-
New-onset diabetes after transplantation.J Heart Lung Transplant. 2004 May;23(5 Suppl):S194-201. doi: 10.1016/j.healun.2004.03.007. J Heart Lung Transplant. 2004. PMID: 15093805 Review.
Cited by
-
Progress of new-onset diabetes after liver and kidney transplantation.Front Endocrinol (Lausanne). 2023 Feb 8;14:1091843. doi: 10.3389/fendo.2023.1091843. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843576 Free PMC article. Review.
-
Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.J Diabetes Investig. 2021 Jan;12(1):109-122. doi: 10.1111/jdi.13317. Epub 2020 Jul 12. J Diabetes Investig. 2021. PMID: 32506801 Free PMC article.
-
Validation of Identified Susceptible Gene Variants for New-Onset Diabetes in Renal Transplant Recipients.J Clin Med. 2019 Oct 16;8(10):1696. doi: 10.3390/jcm8101696. J Clin Med. 2019. PMID: 31623129 Free PMC article.
-
Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies.Med Sci Monit. 2019 Feb 10;25:1102-1104. doi: 10.12659/MSM.914340. Med Sci Monit. 2019. PMID: 30739121 Free PMC article.
-
Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study.Arch Endocrinol Metab. 2018;62(6):597-601. doi: 10.20945/2359-3997000000084. Arch Endocrinol Metab. 2018. PMID: 30624499 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
